Skip to main content
. 2020 Jun 30;123(6):942–954. doi: 10.1038/s41416-020-0943-2

Fig. 3. Microvascular endothelial cells express CCR6 on their cell surface.

Fig. 3

a Flow cytometric analysis of podoplanin and CCR6 protein surface expression in podoplanin-positive lymphatic microvascular endothelial cells (LEC) or podoplanin-negative blood microvascular endothelial cells (BEC) (black line). Filled histogram shows isotype control. b Immunofluorescence analysis of CCR6 (red) expression of LECs and BECs [scale bars represent 50 µm]. c Immunofluorescence analysis of CD31 (green) and CCR6 (red) expression in marginal zones of a breast cancer tumour and melanoma demonstrates the co-localisation of CCR6 with microvessels in the tumour microenvironment [scale bars represent 25 µm]. CCR6 seems also expressed by cancer cells, stromal cells and immune cells infiltrating the tumour.